Johnson & Johnson shares were flat in trading Monday as legal troubles clouded its financial outlook.

The U.S. Food and Drug Administration has cleared the expanded use of the Vidas Brahms PCT Assay to help health care providers determine if antibiotic treatment should be started or stopped in...

This self-taught formulator and regulatory expert grew Turn Therapeutics into a disruptive enterprise with nothing but a credit line, Google and the FDA help desk.

A study of nearly 65,000 people suggests that devices coated with a drug called paclitaxel that are used for widening blocked arteries in legs and feet are safe and not linked to an increase in deaths -- a finding that contradicts smaller studies that led to the FDA issuing a safety alert about the use of paclitaxel-coated stents and balloons for arterial revascularization in the lower limbs in January 2019.

There are increasing concerns about the popular heartburn drug Zantac and its generic version because of a chemical that could lead to cancer. Three large pharmacy chains in the U.S. recently pulled the drugs off shelves, following an FDA alert about an "impurity" in the medication. Dr. Jon LaPook recently spoke to two groups of researchers who suspect the problem could be serious for consumers.

The FDA recently warned about a potentially dangerous impurity in the popular heartburn drug Zantac. The nation's three largest pharmacy chains reacted by pulling it from store shelves. Dr. Jon LaPook reports.

Small amounts of a cancer-causing chemical have been found in the popular heartburn medication Zantac, as well is in generic forms of the drug, known as Ranitidine. The FDA is not issuing a recall and says patients can continue taking the medication. Zantac's maker says it takes patient safety seriously and is committed to working with the FDA. Dr. David Agus joins "CBS This Morning: Saturday" to discuss what consumers need to know.

The U.S. Food and Drug Administration has approved the first generic versions of Strattera (atomoxetine) to treat attention-deficit/hyperactivity disorder (ADHD) in pediatric and adult patients.